INDICATIONS FOR DIAGNOSTIC LAPAROSCOPY IN VARIOUS STAGES OF TREATMENT OF PATIENTS WITH OVARIAN CANCER
https://doi.org/10.21294/1814-4861-2016-15-6-61-65
Abstract
About the Author
A. S. KhadzhimbaRussian Federation
Khadzhimba Anzhella S. - physician oncologist of Gynecologic Oncology Department.
68 A, Leningradskaya Street, 197758-Saint-Petersburg, Russia. E-mail: Khadzhimba@gmail.com
References
1. Gulo Е.I., Maximov S.Ya., Livshits М.А., Shcherbakov А.М. Second-look surgery and diagnostic laparoscopy in combined modality treatment of ovarian cancer patient. Questions Oncology. 1998; 44 (2): 205–210. [in Russian]
2. Poddubny B.К., Gubin А.N., Blyumenberg А.G., Vakurova Е.А. Current state of laparoscopy in diagnosis of ovarian cancer and its recurrence. Proceedings of the 7-th All-Russian Cancer Congress. М., 2003; 196–197. [in Russian]
3. Ash A.K., Badawy A., Mohammed H., Magos A.L. Laparoscopy and spread of ovarian cancer. Lancet. 1995 Sep 9; 346 (8976): 709–10.
4. Bruce J. Ramshaw M.D. Laparascopic Surgery for Cancer Patients. CA Cancer J. Clin. 1997; 47: 327–350.
5. Chauvet M.P., Leblanc E., Querleu D. Laparoscopy and ovarian carcinoma. Eur J Gynaecol Oncol. 2001; XXII (suppl. 2001): 28.
6. Childers J.M., Lang J., Surwitt E.A., Hatch K.D. Laparoscopic surgical staging of ovarian cancer. Gynecol Oncol. 1995 Oct; 59 (1): 25–33. doi: 10.1006/gyno.1995.1263.
7. Soper J.T., Johnson P., Johnson V., Berchuk A., Clarke-Pearson D.L. Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma. Obstet Gynecol. 1992 Dec; 80 (6): 949–53.
8. Harter P., du Bois A., Hahmann M., Hasenburg A., Burges A., Loibl S., Gropp M., Huober J., Fink D., Schröder W., Muenstedt K., Schmalfeldt B., Emons G., Pfisterer J., Wollschlaeger K., Meerpohl H.G., Breitbach G.P., Tanner B., Sehouli J.; Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Committee; AGO Ovarian Cancer Study Group. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial. Ann Surg Oncol. 2006 Dec; 13 (12): 1702–10. doi: 10.1245/s10434-006-9058-0.
9. Rose P.G., Nerenstone S., Brady M.F., Clarke-Pearson D., Olt G., Rubin S.C., Moore D.H., Small J.M.; Gynecologic Oncology Group. Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med. 2004; 351: 2489–2497. doi: 10.1056/NEJMoa041125.
10. Bernard W.S., Christopher P.W. World cancer report 2014. World Health Organization. 2014.
11. Griffiths C.T., Parker L.M., Lee S., Finkler N.J. The effect of residual mass size on response to chemotherapy after surgical cytoreduction for advanced ovarian cancer: long-term results. Int J Gynecol Cancer. 2002 Jul-Aug; 12 (4): 323–31.
12. Selman A.E., Copeland L.J. Surgical management of recurrent cervical cancer. Yonsei Med J. 2002 Dec; 43 (6): 754–62. doi: 10.3349/ymj.2002.43.6.754.
13. Rustin G.J., Van der Burg M.E., Griffin C.L., Guthrie D., Lamont A., Jayson G.C., Kristensen G., Mediola C., Coens C., Qian W., Parmar M.K., Swart A.M.; MRC OV05; EORTC 55955 investigators. Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial Lancet. 2010 Oct 2; 376 (9747): 1155–63. doi: 10.1016/S0140-6736(10)61268-8.
Review
For citations:
Khadzhimba A.S. INDICATIONS FOR DIAGNOSTIC LAPAROSCOPY IN VARIOUS STAGES OF TREATMENT OF PATIENTS WITH OVARIAN CANCER. Siberian journal of oncology. 2016;15(6):61-65. (In Russ.) https://doi.org/10.21294/1814-4861-2016-15-6-61-65